CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 77 filers reported holding CYTOSORBENTS CORP in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $56,000 | -37.1% | 17,653 | -17.2% | 0.00% | – |
| Q4 2021 | $89,000 | -53.6% | 21,321 | -9.8% | 0.00% | – |
| Q3 2021 | $192,000 | -55.2% | 23,625 | -58.5% | 0.00% | -100.0% |
| Q2 2021 | $429,000 | -20.6% | 56,880 | -8.5% | 0.00% | 0.0% |
| Q1 2021 | $540,000 | +9.1% | 62,166 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $495,000 | -0.2% | 62,166 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $496,000 | -3.7% | 62,166 | +19.6% | 0.00% | 0.0% |
| Q2 2020 | $515,000 | +41.1% | 51,994 | +10.0% | 0.00% | 0.0% |
| Q1 2020 | $365,000 | +102.8% | 47,278 | +1.2% | 0.00% | – |
| Q4 2019 | $180,000 | -23.4% | 46,733 | 0.0% | 0.00% | – |
| Q3 2019 | $235,000 | -23.9% | 46,733 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $309,000 | -12.7% | 46,733 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $354,000 | -3.3% | 46,733 | +3.3% | 0.00% | 0.0% |
| Q4 2018 | $366,000 | -37.3% | 45,251 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $584,000 | +18.0% | 45,251 | +4.1% | 0.00% | 0.0% |
| Q2 2018 | $495,000 | – | 43,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |